KR890013173A - 시클로말토덱스트린 글루카노트랜스퍼라제 및 그의 제조방법 - Google Patents

시클로말토덱스트린 글루카노트랜스퍼라제 및 그의 제조방법 Download PDF

Info

Publication number
KR890013173A
KR890013173A KR1019890001328A KR890001328A KR890013173A KR 890013173 A KR890013173 A KR 890013173A KR 1019890001328 A KR1019890001328 A KR 1019890001328A KR 890001328 A KR890001328 A KR 890001328A KR 890013173 A KR890013173 A KR 890013173A
Authority
KR
South Korea
Prior art keywords
cyclomaltodextrin glucanotransferase
culture
stable
molecular weight
hours
Prior art date
Application number
KR1019890001328A
Other languages
English (en)
Other versions
KR910002852B1 (ko
Inventor
고끼 호리꼬시
Original Assignee
오다 미노루
리까가꾸 겡꾸쇼
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오다 미노루, 리까가꾸 겡꾸쇼 filed Critical 오다 미노루
Publication of KR890013173A publication Critical patent/KR890013173A/ko
Application granted granted Critical
Publication of KR910002852B1 publication Critical patent/KR910002852B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1051Hexosyltransferases (2.4.1)
    • C12N9/1074Cyclomaltodextrin glucanotransferase (2.4.1.19)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/18Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07Bacillus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/832Bacillus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

내용 없음.

Description

시클로말토덱스트린 글루카노트랜스피라제 및 그의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 본 발명의 CGT 아제 사용시 α,β, γ 및 총 CD의 시간-경과에 따른 변화를 나타낸다.
제2도 및 CGT 아제활성에 대한 pH효과 및 온도 효과를 각각 나타낸다.
제3도는 효소의 pH- 및 열-안정성의 프로필을 나타낸다.

Claims (5)

  1. (a) 작용 : 전분 및 글리코겐과 같은 α-1,4-글루칸, 또는 그의 부분 가수분해물의 α-1,4-글루코피라노시드 결합을 절단하고 그것을 시클로덱스트린을 형성하도록 전이시켜 CDs-생성반응의 초기 반응 생성물 로서 β-시클로덱스트린을 제조함; (b) 기질특이성 : 사슬 길이가 말토트리오스의 길이보다 짧지않은 α-1,4-글루코피라노시드 결합을 갖는 말토올리고사카라이드와 반응하여 기질간의 분자간 커플링 및 불균화 반응에 의해 다양한 분자량을 갖는 각종 말토올리고사카라이드 및 시클로덱스트린을 제조함; (c) 최적 pH 약 65 ; (d) 안정 pH pH 6∼9, 40℃에서 2시간동안 안정함 ; (e) 최적온도 : 약 65℃ ; (f) 불활성화 조건 : pH4.5 및 11.5, 40℃의 온도에서 2시간의 처리로 및 pH 6, 75℃에서 15분간의 처리로 완전히 불활성화됨 ; (g)열안정성 : pH 6의 조건하에서 5분동안 50℃까지 안정하며, 60℃ 및 70℃에서의 잔류활성이 동일조건하에서 각각 95% 및 20%임 ; (h) 억제 : 수은(II) 또는 구리(II)에 의해 억제됨. (i) 활성화 및 안정화 : 칼슘에 의해 안정화됨 ; (j) 분자량(SDS폴리아크릴아미드겔 전기영동) : 36000±1000 ; (k) 등전점(크로마토포커싱) : 4.8±0.1의 물리적 특성을 갖는 시클로말토덱스트린 글루카노트랜스퍼라제.
  2. 바실루스 코아굴란스(Bacillus cogulans)에 속하는 시클로말토덱스트린 글루카노트랜스퍼라제 생산 미생물을 배양하고 수득된 배양 브로쓰로부터 시클로말토덱스트린 글루카노트랜스퍼라제를 수집함을 특징으로하는 시클로말토덱스트린 글루카노트랜스퍼라제의 제조방법.
  3. 제2항에 있어서, 바실루스 코아굴란스에 속하는 시클로말토덱스트린 글루카노트랜스퍼라제 생산 미생물이 세균 FERM BP-2258인 제조방법.
  4. 제2항에 있어서, 배양을 30∼60℃에서 호기적으로 수행하는 제조방법.
  5. 제2항에 있어서, 배양을 위해 사용되는 배양액의 pH가 5.8∼7 5의 범위인 제조방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890001328A 1988-02-04 1989-02-04 시클로말토덱스트린 글루카노트랜스퍼라제 및 그의 제조방법 KR910002852B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP63024478A JPH01199575A (ja) 1988-02-04 1988-02-04 新規なサイクロマルトデキストリン・グルカノトランスフェラーゼ及びその製造法
JP63-24478 1988-02-04
JP88-24478 1988-02-04

Publications (2)

Publication Number Publication Date
KR890013173A true KR890013173A (ko) 1989-09-21
KR910002852B1 KR910002852B1 (ko) 1991-05-06

Family

ID=12139283

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890001328A KR910002852B1 (ko) 1988-02-04 1989-02-04 시클로말토덱스트린 글루카노트랜스퍼라제 및 그의 제조방법

Country Status (6)

Country Link
US (2) US5019507A (ko)
EP (1) EP0327099B1 (ko)
JP (1) JPH01199575A (ko)
KR (1) KR910002852B1 (ko)
DE (1) DE68909625T2 (ko)
DK (1) DK50889A (ko)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3194145B2 (ja) * 1989-09-28 2001-07-30 株式会社林原生物化学研究所 4G―α―D―グルコピラノシルルチンとその製造方法並びに用途
JP3060232B2 (ja) * 1990-04-29 2000-07-10 株式会社林原生物化学研究所 α―グリコシル ナリンジンとその製造方法並びに用途
DE4029287A1 (de) * 1990-09-14 1992-03-19 Sueddeutsche Kalkstickstoff Verfahren zur herstellung von cholesterinreduziertem eigelb
JP2896598B2 (ja) * 1990-10-06 1999-05-31 株式会社林原生物化学研究所 ラクトネオトレハロースとその製造方法並びに用途
EP0916346A3 (en) 1991-09-20 2000-12-06 Glaxo Group Limited NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis
EP0975227B1 (en) * 1997-04-18 2005-11-09 Ganeden Biotech, Inc. Topical use of probiotic bacillus spores to prevent or control microbial infections
US6716435B1 (en) * 1997-04-18 2004-04-06 Ganeden Biotech, Inc. Absorbent product containing absorbent structure and Bacillus coagulans
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
US6811786B1 (en) * 1999-04-01 2004-11-02 Ganeden Biotech, Inc. Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions
EP1719518A1 (en) 1998-08-07 2006-11-08 Ganeden Biotech, Inc. Compositions comprising bacillus coagulans for increasing the solubility and bioavailability of nutritional minerals
US7767203B2 (en) * 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
US6461607B1 (en) 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
ES2221624T3 (es) * 1999-08-26 2005-01-01 Ganeden Biotech, Inc. Uso de aceite de emu como vehiculo para mediaciones antifungicas, antibacterianas y antiviricas.
US6849256B1 (en) * 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
EP2422804A1 (en) 2004-06-17 2012-02-29 Amano Enzyme USA., Ltd. Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers
WO2009032121A1 (en) * 2007-08-29 2009-03-12 Ganeden Biotech, Inc. Compositions and methods for enhancing paper product degradation
SI2211626T1 (sl) 2007-08-29 2019-12-31 Ganeden Biotech, Inc. Pekovski izdelki
PL2638807T3 (pl) * 2007-10-16 2021-08-23 Ganeden Biotech, Inc. Kompozycje napojów
WO2009099562A2 (en) * 2008-01-30 2009-08-13 Ganeden Biotech, Inc. Compositions and methods for cleaning surfaces
US7788209B2 (en) * 2008-05-05 2010-08-31 United Technologies Corporation Hybrid fault reasoning and guided troubleshooting system that uses case-based reasoning and model-based reasoning
JP5677304B2 (ja) * 2008-10-16 2015-02-25 ガネーデン バイオテック インコーポレイテッド プロバイオティクス穀物組成物
WO2010127132A1 (en) 2009-04-29 2010-11-04 Ganeden Biotech, Inc. Inactivated bacterial cell formulation
WO2011130487A1 (en) 2010-04-14 2011-10-20 Ganeden Biotech, Inc. Probiotic confection and lipid compositions
WO2012135499A1 (en) 2011-03-31 2012-10-04 Ganeden Biotech, Inc. Probiotic sports nutrition compositions
CN108220362B (zh) * 2018-03-07 2021-07-16 江南大学 一种利用环糊精水解酶制备特定聚合度麦芽低聚糖的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5327791B2 (ko) * 1973-10-02 1978-08-10
JPS5953038B2 (ja) * 1979-04-07 1984-12-22 メルシャン株式会社 サイクロデキストリンの製造法

Also Published As

Publication number Publication date
US5102800A (en) 1992-04-07
EP0327099B1 (en) 1993-10-06
EP0327099A2 (en) 1989-08-09
DK50889D0 (da) 1989-02-03
DE68909625D1 (de) 1993-11-11
EP0327099A3 (en) 1990-06-27
JPH01199575A (ja) 1989-08-10
DE68909625T2 (de) 1994-05-05
DK50889A (da) 1989-08-05
US5019507A (en) 1991-05-28
KR910002852B1 (ko) 1991-05-06

Similar Documents

Publication Publication Date Title
KR890013173A (ko) 시클로말토덱스트린 글루카노트랜스퍼라제 및 그의 제조방법
KR830010192A (ko) 디브랜칭 효소 생성물, 그 제법 및 그 이용 방법
ATE405639T1 (de) Cyclodextrin glucantransferase, verfahren zu deren herstellung und verfahren zur herstellung von cyclodextrin unter verwendung dieses enzyms
KR890701730A (ko) 열안정성 시클로덱스트린 글리코실 트란스페라제 그의 제조방법 및 이용
Goyal et al. Optimal conditions for production of dextransucrase from Leuconostoc mesenteroides NRLL B‐512F and its properties
JPH0547199B2 (ko)
US5387516A (en) Heat stable debranching enzyme from a Bacillus microorganism
US5110734A (en) Purified cyclodextrinase
EP0506790A1 (en) METHOD FOR THE ENZYMATIC CONVERSION OF STARCH IN CYCLODEXTRINE.
ATE87651T1 (de) Thermostabile amylasen und pullulanasen aus 2 anaeroben mikroorganismen.
US4001084A (en) Process for producing isoamylase
KR970074929A (ko) 치아우식증 원인세균인 스트렙토코커스 뮤탄스(Streptococcus mutans)의 세포벽을 용해하는 용해효소와 그의 생산 미생물
Rhee et al. Properties of dextransucrase from Leuconostoc mesenteroides isolated from Sikhae
JPS6225977A (ja) 新規なアミラ−ゼ
KR960007741B1 (ko) 신규 α-1, 6-글루코시다제 및 그의 제조방법
CA2212577A1 (en) Bacillus proteases
US4001083A (en) Process for producing isoamylase
JPH0632611B2 (ja) γ―サイクロデキストリン合成酵素及びその製造法
JPH0358784A (ja) 新規なシクロマルトデキストリナーゼ及びその製造方法
CA2212456A1 (en) Bacillus proteases
JPH0681598B2 (ja) 澱粉の糖化によるグルコースの製造方法
JPS6344360B2 (ko)
JPS62126993A (ja) マルト−スの製法
ES2007758A6 (es) Un procedimiento para la obtencion de alfa-amilasas termoestables, por cultivo de microorganismos superproductores a altas temperaturas.
JPH01218587A (ja) 新規酵素、その製造法及び生産菌

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19941229

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee